A Preview Of BioXcel Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
BioXcel Therapeutics (NASDAQ:BTAI) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-1.72. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $7.39, down 52.82% over the last 52-week period.
August 11, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BioXcel Therapeutics is expected to report an EPS of $-1.72. The company's stock price has shown to be sensitive to earnings reports and guidance. The stock is currently down 52.82% over the last year.
The company's earnings report is a key event that could influence its stock price. Given the mixed historical performance and the current negative trend in the stock price, the impact of the earnings report could go either way. Hence, the score is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100